SEC Comment Letter for Park Ha Biological Technology Co., (BYAH) — Sep 9, 2025
Park Ha Biological Technology Co., Ltd.
Date: Sept. 9, 2025 · CIK: 0001986247 · Accession: 0000000000-25-009738
AI Filing Summary & Sentiment
Letter
September 9, 2025 Xiaoqiu Zhang Chief Executive Officer Park Ha Biological Technology Co., Ltd. 901, Building C Phase 2, Wuxi International Life Science Innovation Campus 196 Jinghui East Road Xinwu District, Wuxi, Jiangsu Province People’s Republic of China 214000 Re:Park Ha Biological Technology Co., Ltd. Draft Registration Statement on Form F-1 Submitted September 5, 2025 CIK No. 0001986247 Dear Xiaoqiu Zhang: This is to advise you that we do not intend to review your registration statement. We request that you publicly file your registration statement and non-public draft submission on EDGAR at least two business days prior to the requested effective date and time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Margaret Sawicki at 202-551-7153 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Kyle Leung, Esq.
Show Raw Text
September 9, 2025
Xiaoqiu Zhang
Chief Executive Officer
Park Ha Biological Technology Co., Ltd.
901, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
Re:Park Ha Biological Technology Co., Ltd.
Draft Registration Statement on Form F-1
Submitted September 5, 2025
CIK No. 0001986247
Dear Xiaoqiu Zhang:
This is to advise you that we do not intend to review your registration statement.
We request that you publicly file your registration statement and non-public draft
submission on EDGAR at least two business days prior to the requested effective date and
time. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Margaret Sawicki at 202-551-7153 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Kyle Leung, Esq.